← Back to PRME

Prime Medicine, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 07/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 07/11/2025Jun 2024Filed 07/11/2025Mar 2024Filed 07/11/2025
$1.2$1.1$1.5$0.2$0$0.6
−$42−$49−$51−$53−$52−$53−$55−$46
−$0.24−$0.28−$0.32−$0.41−$0.40−$0.44−$0.46−$0.44
177177161129131120119104

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.